MTEM - Molecular Templates Inc
Previous close
1.52
0 0%
Share volume: 2,292
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.52
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-13 | 2022-08-12 | 2022-11-10 | 2023-03-30 | 2023-05-15 | 2023-08-10 | 2023-11-13 | |
| Assets | ||||||||
| Total Assets | 163.165 M | 140.891 M | 118.646 M | 97.548 M | 78.505 M | 35.512 M | 44.061 M | |
| Current Assets | 132.385 M | 111.178 M | 87.185 M | 68.298 M | 51.624 M | 11.823 M | 22.700 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 7.866 M | 6.753 M | 7.740 M | 7.249 M | 7.115 M | 6.597 M | 6.889 M | |
| Short Term Investments | 7.866 M | 6.753 M | 7.740 M | 7.249 M | 7.115 M | 6.597 M | 6.889 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 2.838 M | 274.000 K | 0.000 | |
| Current Cash | 124.519 M | 104.425 M | 79.445 M | 61.049 M | 41.671 M | 4.952 M | 15.811 M | |
| Total Non-current Assets | 30.780 M | 29.713 M | 31.461 M | 29.250 M | 26.881 M | 23.689 M | 21.361 M | |
| Property Plant Equipment | 18.634 M | 17.913 M | 16.347 M | 14.632 M | 12.814 M | 10.158 M | 8.578 M | |
| Other Assets | 3.940 M | 4.006 M | 3.994 M | 3.486 M | 3.415 M | 3.368 M | 3.116 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 163.165 M | 140.891 M | 118.646 M | 97.548 M | 78.505 M | 35.512 M | 44.061 M | |
| Total liabilities | 115.683 M | 114.854 M | 114.494 M | 112.680 M | 80.415 M | 44.190 M | 37.260 M | |
| Total current liabilities | 45.024 M | 46.375 M | 50.222 M | 57.082 M | 29.900 M | 26.937 M | 21.512 M | |
| Accounts Payable | 0.000 | 1.641 M | 1.085 M | 504.000 K | 2.718 M | 4.669 M | 2.583 M | |
| Other liabilities | 25.913 M | 24.360 M | 15.910 M | 7.199 M | 2.478 M | 6.224 M | 5.352 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 35.737 M | 35.675 M | 35.940 M | 36.168 M | 36.402 M | 0.000 | 0.000 | |
| Other liabilities | 25.913 M | 24.360 M | 15.910 M | 7.199 M | 2.478 M | 6.224 M | 5.352 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 47.482 M | 26.037 M | 4.152 M | -15.132 M | -1.910 M | -8.678 M | 6.801 M | |
| Common stock | 56.305 M | 56.330 M | 56.351 M | 56.352 M | 56.352 M | 56.352 M | 5.093 M | |
| Retained earnings | -373.661 M | -398.081 M | -422.719 M | -444.768 M | -433.923 M | -444.791 M | -448.944 M |